content

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that partner, SK bioscience, has received a...

Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older

Roche announced that the US FDA has approved a supplemental New Drug Application (sNDA) for Xofluzaยฎ (baloxavir marboxil) for the treatment of acute uncomplicated...

Thermo Fisher Announced FDA Approves First NGS-Based Companion Diagnostic to Aid in Selecting Non-Small C

The U.S. FDA has granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients whose...

Gerresheimer invests up to 94 million Dollar in US production facility

Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, announced investments to rapidly expand...

Almac Group Announces $65M Expansion of North American Headquarters in Pennsylvania

Almac Group, the global contract development and manufacturing organisation, today announces a $65 million, 100,000 ft2expansion of clinical supply operations at the companyโ€™s North...

Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd. from private...

Charles River Receives EMA Approval to Produce Allogeneic Cell Therapy

Charles River Laboratories, International Inc. announced it has received regulatory approval, in the form of Good Manufacturing Practice (GMP) certification, to commercially produce allogeneic...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read